EUVIMEDOpdag EUVIMED
Open access · CC BY-NC 4.0

Changes in Ki-67 and p53 Expression Following Neoadjuvant Chemoradiotherapy in Rectal Adenocarcinoma: A Retrospective Study

Dua Abuquteish, Raya Marji, Maher Sughayer, Fareed Barakat, Maxim Al-Ashhab, Bashar Al Zoubi, Aya Alquran, Sara Aljfout, Lara Al-Natour, Mohammad Al-Qudah, Najib Haboubi

World Journal of Oncology · 2026-12 · 17 (6) · 820-829

DOI: 10.14740/wjon2845 ↗

At a glance

Journal article in World Journal of Oncology, 2026-12. Written by Dua Abuquteish and 10 co-authors. The full text is freely available (open access, CC BY-NC 4.0).

AbstractBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Background

Ki-67 is widely investigated for its role in assessing colorectal cancer aggressiveness, prognosis, and treatment response. High Ki-67 is associated with poor differentiation and advanced stage, yet there is no consensus on the optimal cutoff value that defines clinically meaningful expression. p53 overexpression was also correlated with high Ki-67. This study aimed to evaluate the effect of neoadjuvant chemoradiotherapy (nCRT) on Ki-67 and p53 expressions in rectal adenocarcinoma, explore their association with pathological tumor response using different Ki-67 cutoff thresholds, and assess their relationship with clinicopathological features.

Methods

A total of 45 patients with rectal adenocarcinoma treated with standard nCRT followed by surgery at a cancer center (from June 2023 to June 2024) were retrospectively included. Pre- and post-nCRT biopsy and resection specimens were immunostained for Ki-67 and p53. Two pathologists evaluated expression levels. Paired t-tests and regression analyses were used to assess biomarker changes and correlations with tumor regression score (TRS), pathological features, and clinical parameters.

Results

Ki-67 expression significantly decreased after nCRT (mean reduction: 32.9%, P < 0.001). A greater decline, especially at ≥ 50% and ≥ 70% cutoff thresholds, was associated with better TRS. Higher baseline Ki-67 was associated with lymphovascular invasion (P < 0.001). p53 showed only modest reduction and was not significantly associated with pathological tumor response.

Conclusions

Changes in Ki-67 expression following nCRT were associated with pathological tumor response, whereas pre-treatment Ki-67 and p53 expressions were not. Larger prospective studies are needed to validate these findings and further define the clinical utility of Ki-67 in rectal adenocarcinoma.

Cite

APA

Abuquteish, D., Marji, R., Sughayer, M., Barakat, F., Al-Ashhab, M., Zoubi, B. A., Alquran, A., Aljfout, S., Al-Natour, L., Al-Qudah, M., & Haboubi, N. (2026). Changes in Ki-67 and p53 Expression Following Neoadjuvant Chemoradiotherapy in Rectal Adenocarcinoma: A Retrospective Study. World Journal of Oncology, 17(6), 820-829. https://doi.org/10.14740/wjon2845

Vancouver

Abuquteish D, Marji R, Sughayer M, Barakat F, Al-Ashhab M, Zoubi BA, et al. Changes in Ki-67 and p53 Expression Following Neoadjuvant Chemoradiotherapy in Rectal Adenocarcinoma: A Retrospective Study. World Journal of Oncology. 2026;17(6):820-829. doi:10.14740/wjon2845

BibTeX
@article{Abuquteish2026,
  author = {Abuquteish, Dua and Marji, Raya and Sughayer, Maher and Barakat, Fareed and Al-Ashhab, Maxim and Zoubi, Bashar Al and Alquran, Aya and Aljfout, Sara and Al-Natour, Lara and Al-Qudah, Mohammad and Haboubi, Najib},
  title = {Changes in Ki-67 and p53 Expression Following Neoadjuvant Chemoradiotherapy in Rectal Adenocarcinoma: A Retrospective Study},
  journal = {World Journal of Oncology},
  year = {2026},
  volume = {17},
  number = {6},
  pages = {820--829},
  doi = {10.14740/wjon2845}
}
Start for free →